Literature DB >> 24257898

D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice.

N Granado1, S Ares-Santos, R Moratalla.   

Abstract

MDMA, an addictive psychostimulant-consumed worldwide, has the ability to induce neurotoxic effects and addiction in laboratory animals and in humans through its effects on monoaminergic systems. MDMA-induced neurotoxicity in mice occurs primarily in dopaminergic neurons and does not significantly affect the serotonergic system. As the neurotoxic effects of MDMA in mice involve excessive dopamine (DA) release, DA receptors are highly likely to play a role in MDMA neurotoxicity, but the specific dopamine receptor subtypes involved have not previously been determined definitively. In this study, dopamine D1 and D4 receptor knock-out mice (D1R(-/-) and D4R(-/-)) were used to determine whether these receptors are involved in MDMA neurotoxicity. D1R inactivation attenuated MDMA-induced hyperthermia, decreased the reduction of dopamine and dopamine metabolite levels, and protected against dopamine terminal loss and reactive astrogliosis as determined in the striatum, 7 days after MDMA treatment. In sharp contrast, inactivation of D4R did not prevent hyperthermia or the neurotoxic effects of MDMA. Altogether, these results indicate that D1R, but not D4R, plays a significant role in the dopaminergic striatal neurotoxicity observed after exposure to MDMA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24257898     DOI: 10.1007/s12640-013-9438-8

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  54 in total

1.  A role for D1 dopamine receptors in striatal methamphetamine-induced neurotoxicity.

Authors:  Danielle M Friend; Kristen A Keefe
Journal:  Neurosci Lett       Date:  2013-08-28       Impact factor: 3.046

2.  Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine.

Authors:  S Ares-Santos; N Granado; I Oliva; E O'Shea; E D Martin; M I Colado; R Moratalla
Journal:  Neurobiol Dis       Date:  2011-11-13       Impact factor: 5.996

3.  ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.

Authors:  Nancy Pavón; Ana B Martín; Ainhoa Mendialdua; Rosario Moratalla
Journal:  Biol Psychiatry       Date:  2005-09-01       Impact factor: 13.382

4.  Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.

Authors:  Noelia Granado; Sara Ares-Santos; Idaira Oliva; Esther O'Shea; Eduardo D Martin; M Isabel Colado; Rosario Moratalla
Journal:  Neurobiol Dis       Date:  2011-02-15       Impact factor: 5.996

Review 5.  Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.

Authors:  M Isabel Colado; Esther O'Shea; A Richard Green
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

6.  Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury.

Authors:  A J Eisch; J F Marshall
Journal:  Synapse       Date:  1998-12       Impact factor: 2.562

7.  Brain concentrations of d-MDMA are increased after stress.

Authors:  Elizabeth Anne Johnson; James P O'Callaghan; Diane B Miller
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

8.  Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

Authors:  M J LaVoie; T G Hastings
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

9.  Evaluation of nigrostriatal neurodegeneration and neuroinflammation following repeated intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in mice, an experimental model of Parkinson's disease.

Authors:  Fabrine S M Tristão; Majid Amar; Ines Latrous; Elaine A Del-Bel; Rui D Prediger; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2013-05-21       Impact factor: 3.911

10.  Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses.

Authors:  M Xu; R Moratalla; L H Gold; N Hiroi; G F Koob; A M Graybiel; S Tonegawa
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

View more
  5 in total

1.  Concurrent Inhibition of Vesicular Monoamine Transporter 2 Does Not Protect Against 3,4-Methylenedioxymethamphetamine (Ecstasy) Induced Neurotoxicity.

Authors:  Aram B Cholanians; Andy V Phan; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2019-07-01       Impact factor: 4.849

2.  3,4-Methylenedioxypyrovalerone (MDPV)-induced conditioned taste avoidance in the F344/N and LEW rat strains.

Authors:  Heather E King; Bradley Wetzell; Kenner C Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2014-10-02       Impact factor: 3.533

3.  Opposing aging-related shift of excitatory dopamine D1 and inhibitory D3 receptor protein expression in striatum and spinal cord.

Authors:  Benjamin E Keeler; Perrine Lallemand; Mukund M Patel; Lisandra E de Castro Brás; Stefan Clemens
Journal:  J Neurophysiol       Date:  2015-11-11       Impact factor: 2.714

4.  Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.

Authors:  Anna Maria Górska; Katarzyna Kamińska; Agnieszka Wawrzczak-Bargieła; Giulia Costa; Micaela Morelli; Ryszard Przewłocki; Grzegorz Kreiner; Krystyna Gołembiowska
Journal:  Neurotox Res       Date:  2017-11-13       Impact factor: 3.911

Review 5.  Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies.

Authors:  Giulia Costa; Maria Antonietta De Luca; Gessica Piras; Jacopo Marongiu; Liana Fattore; Nicola Simola
Journal:  Neural Regen Res       Date:  2020-05       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.